1
|
Affiliation(s)
- Gary D Novack
- PharmaLogic Development Inc., San Rafael, CA, USA; Department of Ophthalmology & Visual Sciences, University of California, Davis, USA.
| |
Collapse
|
2
|
Statement of the German Society of Ophthalmology, the German Retina Society, and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity : Released: 18 May 2020. Ophthalmologe 2021; 118:68-77. [PMID: 33146773 DOI: 10.1007/s00347-020-01250-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
3
|
Novack GD. Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies. J Ocul Pharmacol Ther 2021; 37:191-192. [PMID: 33761283 DOI: 10.1089/jop.2021.29079.gdn] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Gary D Novack
- PharmaLogic Development, Inc., San Rafael, California, USA.,Department of Ophthalmology, University of California, Davis, School of Medicine, Sacramento, California, USA
| |
Collapse
|